Lumos Diagnostics Holdings Limited (ASX:LDX)

ASX:LDX Revenue

Lumos Diagnostics Holdings had revenue of $6.12M USD in the half year ending December 31, 2025, with 121.26% growth. This brings the company's revenue in the last twelve months to $12.21M, down -16.75% year-over-year. In the fiscal year ending June 30, 2025, Lumos Diagnostics Holdings had annual revenue of $12.40M with 11.40% growth.

• Revenue (ttm): $12.21M
• Revenue Growth: -16.75%
• P/S Ratio: 6.05
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 110.86M AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	12.40M	1.27M	11.40%
Jun 30, 2024	11.13M	596.00K	5.66%
Jun 30, 2023	10.54M	-1.10M	-9.42%
Jun 30, 2022	11.63M	-7.22M	-38.32%
Jun 30, 2021	18.85M	13.06M	225.25%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 17, 2026

Data Sources Report a data error